Immunome, Inc.
IMNM Healthcare Biotechnology
Immunome, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.9 million, down 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 69.8%, EPS fell 30.0% and free cash flow fell 27.0%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow IMNM
Immunome, Inc. (IMNM) EV/Sales
As of 16 October 2026, Immunome, Inc. (IMNM) trades at a EV/Sales of 107×. Over the past ten years it has ranged from 0.0× (December 2023) to 227× (August 2026); the current reading is higher than 88% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 97.2× | 116.42% |
| FY2024 | 44.9× | 678.59% |
| FY2023 | 5.8× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2025 | 43.0× | 116.28% |
| Mar 2025 | 19.9× | (55.69%) |
| Dec 2024 | 44.9× | (29.00%) |
| Sep 2024 | 63.2× | 50.42% |
| 6 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | −2.2× |
| IRON Disc Medicine, Inc. compare | n/m |
| PHVS Pharvaris N.V. compare | n/m |
| VERA Vera Therapeutics, Inc. compare | n/m |
| FTRE Fortrea Holdings Inc. compare | 1.1× |
| NVAX Novavax, Inc. compare | 3.4× |
| VCEL Vericel Corporation compare | 6.2× |
| AGIO Agios Pharmaceuticals, Inc. compare | 12.7× |
| IMNM Immunome, Inc. | 107× |
| Biotechnology industry median | 9.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)